From January 1, 2024 to March 31, 2024, the company has repurchased 915,000 shares, representing 0.46% for CNY 15.39 million. With this, the company has completed the repurchase of 2,020,000 shares, representing 1.02% for CNY 28.79 million under the buyback announced on August 31, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
16.82 CNY | -0.94% | -9.57% | -22.52% |
1st Jan change | Capi. | |
---|---|---|
-22.52% | 463M | |
+31.37% | 588B | |
-2.60% | 364B | |
+20.83% | 326B | |
+5.69% | 285B | |
+14.83% | 239B | |
+9.93% | 210B | |
-6.95% | 200B | |
+10.77% | 167B | |
+0.10% | 161B |
- Stock Market
- Equities
- 002940 Stock
- News Zhejiang AngLiKang Pharmaceutical CO.,LTD.
- Tranche Update on Zhejiang AngLiKang Pharmaceutical CO.,LTD.'s Equity Buyback Plan announced on August 31, 2023.